In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2005 | 26 | Yes |
Popular Name: Yohimbine Hydrochloride Yohimbine Hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 146-48-5 , 51811-82-6 , 65-19-0 , [65-19-0]
(16alpha,17alpha)-17-Hydroxy-yohimban-16-carboxylic acid methyl ester
(16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester
146-48-5; D08685; Yohimbine (DCF)
17-Hydroxy-yohimbane-16-carboxylic acid methyl ester
17-Hydroxyyohimban-16-carboxylic acid methyl ester
17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride
17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester
4-25-00-01237 (Beilstein Handbook Reference)
65-19-0; D06671; Yohimbine hydrochloride (USP)
65-19-0; Prestwick_961; Yohimbine hydrochloride
Antagonil, Yohimbe, Aphrodine hydrochloride, Yohimbine monohydrochloride
Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.
methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate
methyl 17alpha-hydroxyyohimban-16alpha-carboxylate
Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester
Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI)
Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI)
Yohimbine hydrochloride (Antagonil)
Yohimbine Hydrochloride [65-19-0]
YOHIMBINE HYDROCHLORIDE; [65-19-0]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.22 | 8.17 | -43.2 | 3 | 5 | 1 | 67 | 355.458 | 2 | ↓ |
Hi High (pH 8-9.5) | 3.22 | 6.05 | -10.14 | 2 | 5 | 0 | 66 | 354.45 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 3.74 | Bitter DB |
Mp [°C] | 285 - 288 | Acros Organics |
MP | 288-290 °C (dec.)(lit.) | Indofine |
ALOGPS_SOLUBILITY | 3.48e-01 g/l | DrugBank-approved |
Purity | >99% | Fluorochem |
UniProt Database Links | ADA2A_HUMAN; ADA2B_HUMAN; OAR1_LOCMI; OAR1_LYMST; OAR2_LYMST; OAR_DROME | ChEBI |
Therapy | alpha adrenergic blocker, mydriatic, antidepressant | SMDC Pharmakon |
Therapy | alpha2 Adrenoceptor antagonist isolated from Cortnanthe johimbe | SMDC Iconix |
Melting_Point | ca 300? | Alfa-Aesar |
Melting_Point | ca 300° | Alfa-Aesar |
Patent Database Links | EP1700601; EP1762236; US2004092536; US2006040929; US2007112067; US2007190023; US2007196511; US2007212429; US2007232698; US2007238762; US2008280919; WO2006091697; WO2007087367; WO2007098390; WO2007101349 | ChEBI |
SOLUBILITY | H2O: 10 mg/mL | Indofine |
H phrase | H311: Toxic in contact with skin | Acros Organics |
H phrase | H311: Toxic in contact with skin; H373: May cause damage to organs through prolonged or repeated exposure; H331: Toxic if inhaled | Acros Organics |
Target | NULL | Selleck Chemicals |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection | Acros Organics |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection; P312: Call a POISON CENTER or doctor/physician if you feel unwell; P302 + P350: IF ON SKIN: Gently wash with plenty of soap and water; P304 + P340: IF INHALED: Remove victim | Acros Organics |
R phrase | R23/24: Toxic by inhalation and in contact with skin. | Acros Organics |
R phrase | R23/24: Toxic by inhalation and in contact with skin.; R33: Danger of cumulative effects. | Acros Organics |
Reactome Database Links | REACT_15538; REACT_163726; REACT_22239; REACT_22289 | ChEBI |
S phrase | S24/25: Avoid contact with skin and eyes. | Acros Organics |
Hazard | T: Toxic | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1622 | 0.31 | Binding ≤ 10μM |
5HT2C-1-E | Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10000 | 0.27 | Binding ≤ 10μM |
AA3R-1-E | Adenosine Receptor A3 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 95 | 0.38 | Binding ≤ 10μM |
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1057 | 0.32 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 966 | 0.32 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 289 | 0.35 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1 | 0.48 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 49 | 0.39 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 7 | 0.44 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 54 | 0.39 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1 | 0.48 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 54 | 0.39 | Binding ≤ 10μM |
CAC1C-1-E | Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.40 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2000 | 0.31 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2430 | 0.30 | Binding ≤ 10μM |
DRD4-3-E | Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 2000 | 0.31 | Binding ≤ 10μM |
DRD5-1-E | Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2000 | 0.31 | Binding ≤ 10μM |
ADA2A-2-E | Alpha-2a Adrenergic Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 165 | 0.37 | Functional ≤ 10μM |
ADA2B-2-E | Alpha-2b Adrenergic Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 165 | 0.37 | Functional ≤ 10μM |
ADA2C-2-E | Alpha-2c Adrenergic Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 165 | 0.37 | Functional ≤ 10μM |
CP2D6-1-E | Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8 | 0.44 | ADME/T ≤ 10μM |
CP2D6-1-E | Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 80 | 0.38 | ADME/T ≤ 10μM |
DRD2-4-E | Dopamine D2 Receptor (cluster #4 Of 24), Eukaryotic | Eukaryotes | 2000 | 0.31 | Binding ≤ 10μM |
Z104304-1-O | Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other | Other | 360 | 0.35 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 3162 | 0.30 | Functional ≤ 10μM |
Z50587-5-O | Homo Sapiens (cluster #5 Of 9), Other | Other | 1100 | 0.32 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 505 | 0.34 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 95 | 0.38 | Binding ≤ 1μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 1000 | 0.32 | Binding ≤ 1μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 200 | 0.36 | Binding ≤ 1μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 1.1 | 0.48 | Binding ≤ 1μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 1.6 | 0.47 | Binding ≤ 1μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 52 | 0.39 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 1μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 49 | 0.39 | Binding ≤ 1μM |
ADA2A_MOUSE | Q01338 | Alpha-2a Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2A_PIG | P18871 | Alpha-2a Adrenergic Receptor, Pig | 4.4 | 0.45 | Binding ≤ 1μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 1μM |
ADA2B_MOUSE | P30545 | Alpha-2b Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2B_BOVIN | O77700 | Alpha-2b Adrenergic Receptor, Bovin | 49 | 0.39 | Binding ≤ 1μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2C_MOUSE | Q01337 | Alpha-2c Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 1μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 1μM |
CAC1C_RAT | P22002 | Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat | 45 | 0.40 | Binding ≤ 1μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 95 | 0.38 | Binding ≤ 10μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 1000 | 0.32 | Binding ≤ 10μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 200 | 0.36 | Binding ≤ 10μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 1057 | 0.32 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 1.1 | 0.48 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 1.6 | 0.47 | Binding ≤ 10μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 52 | 0.39 | Binding ≤ 10μM |
ADA2A_PIG | P18871 | Alpha-2a Adrenergic Receptor, Pig | 4.4 | 0.45 | Binding ≤ 10μM |
ADA2A_BOVIN | Q28838 | Alpha-2a Adrenergic Receptor, Bovin | 49 | 0.39 | Binding ≤ 10μM |
ADA2A_MOUSE | Q01338 | Alpha-2a Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 10μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 10μM |
ADA2B_MOUSE | P30545 | Alpha-2b Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 10μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 10μM |
ADA2B_BOVIN | O77700 | Alpha-2b Adrenergic Receptor, Bovin | 49 | 0.39 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 0.4 | 0.51 | Binding ≤ 10μM |
ADA2C_MOUSE | Q01337 | Alpha-2c Adrenergic Receptor, Mouse | 0.6 | 0.50 | Binding ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 0.6 | 0.50 | Binding ≤ 10μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 2000 | 0.31 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 1125 | 0.32 | Binding ≤ 10μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 2000 | 0.31 | Binding ≤ 10μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 2000 | 0.31 | Binding ≤ 10μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 2000 | 0.31 | Binding ≤ 10μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 1621.8101 | 0.31 | Binding ≤ 10μM |
5HT2C_MOUSE | P34968 | Serotonin 2c (5-HT2c) Receptor, Mouse | 10000 | 0.27 | Binding ≤ 10μM |
CAC1C_RAT | P22002 | Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat | 45 | 0.40 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 165 | 0.37 | Functional ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 165 | 0.37 | Functional ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 165 | 0.37 | Functional ≤ 10μM |
Z50587 | Z50587 | Homo Sapiens | 1100 | 0.32 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1995.26231 | 0.31 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 505 | 0.34 | Functional ≤ 10μM |
CP2D6_HUMAN | P10635 | Cytochrome P450 2D6, Human | 180 | 0.36 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Class C/3 (Metabotropic glutamate/pheromone receptors) | |
G alpha (i) signalling events |
Description | Species |
---|---|
Adenosine P1 receptors | |
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
CYP2E1 reactions | |
Dopamine receptors | |
Fatty acids | |
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (z) signalling events | |
Miscellaneous substrates | |
Serotonin receptors | |
Xenobiotics |